Small molecules which reverse Urothelial carcinoma in situ
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00009715
TitleSmall molecules which reverse Urothelial carcinoma in situ
DescriptionThe L1000 database was queried in order to identify small molecule perturbations which reverse the Urothelial carcinoma in situ gene expression signature in the Urothelium cell type.
Analysis URLhttp://amp.pharm.mssm.edu/L1000CDS2/#/result/58d1b6d2e467bea600fb8044
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis CuratorJoel.Dudley
CREEDS IDdz:229
Cell TypeUrothelium
Disease NameUrothelial carcinoma in situ
Organismhuman
UMLS CUIC0334267
L1000CDS2 parameters
Directionreverse
Characteristic Direction parameters
Control SamplesGSM71019, GSM71020, GSM71021, GSM71022, GSM71023, GSM71024, GSM71025, GSM71026, GSM71027
Perturbed SamplesGSM71070, GSM71072, GSM71074, GSM71076, GSM71077
Tools used in the analysis
Dataset Accession
L1000CDS2
Published August 2016
An ultra-fast LINCS L1000 Characteristic Direction signature search engine
7756
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE3167
Gene Expression Omnibus
Carcinoma in situ lesions of the urinary bladder
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.